233 related articles for article (PubMed ID: 34341443)
1. A CpG island promoter drives the CXXC5 gene expression.
Yaşar P; Kars G; Yavuz K; Ayaz G; Oğuztüzün Ç; Bilgen E; Suvacı Z; Çetinkol ÖP; Can T; Muyan M
Sci Rep; 2021 Aug; 11(1):15655. PubMed ID: 34341443
[TBL] [Abstract][Full Text] [Related]
2. CXXC5 as an unmethylated CpG dinucleotide binding protein contributes to estrogen-mediated cellular proliferation.
Ayaz G; Razizadeh N; Yaşar P; Kars G; Kahraman DC; Saatci Ö; Şahin Ö; Çetin-Atalay R; Muyan M
Sci Rep; 2020 Apr; 10(1):5971. PubMed ID: 32249801
[TBL] [Abstract][Full Text] [Related]
3. A prelude to the proximity interaction mapping of CXXC5.
Ayaz G; Turan G; Olgun ÇE; Kars G; Karakaya B; Yavuz K; Demiralay ÖD; Can T; Muyan M; Yaşar P
Sci Rep; 2021 Sep; 11(1):17587. PubMed ID: 34475492
[TBL] [Abstract][Full Text] [Related]
4. ThPOK represses CXXC5, which induces methylation of histone H3 lysine 9 in Cd40lg promoter by association with SUV39H1: implications in repression of CD40L expression in CD8+ cytotoxic T cells.
Tsuchiya Y; Naito T; Tenno M; Maruyama M; Koseki H; Taniuchi I; Naoe Y
J Leukoc Biol; 2016 Aug; 100(2):327-38. PubMed ID: 26896487
[TBL] [Abstract][Full Text] [Related]
5. Estradiol-Estrogen Receptor α Mediates the Expression of the CXXC5 Gene through the Estrogen Response Element-Dependent Signaling Pathway.
Yaşar P; Ayaz G; Muyan M
Sci Rep; 2016 Nov; 6():37808. PubMed ID: 27886276
[TBL] [Abstract][Full Text] [Related]
6. CXXC5: A novel regulator and coordinator of TGF-β, BMP and Wnt signaling.
Xiong X; Tu S; Wang J; Luo S; Yan X
J Cell Mol Med; 2019 Feb; 23(2):740-749. PubMed ID: 30479059
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs.
Ma S; Wan X; Deng Z; Shi L; Hao C; Zhou Z; Zhou C; Fang Y; Liu J; Yang J; Chen X; Li T; Zang A; Yin S; Li B; Plumas J; Chaperot L; Zhang X; Xu G; Jiang L; Shen N; Xiong S; Gao X; Zhang Y; Xiao H
J Exp Med; 2017 May; 214(5):1471-1491. PubMed ID: 28416650
[TBL] [Abstract][Full Text] [Related]
8. All and only CpG containing sequences are enriched in promoters abundantly bound by RNA polymerase II in multiple tissues.
Rozenberg JM; Shlyakhtenko A; Glass K; Rishi V; Myakishev MV; FitzGerald PC; Vinson C
BMC Genomics; 2008 Feb; 9():67. PubMed ID: 18252004
[TBL] [Abstract][Full Text] [Related]
9. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
10. Down-Regulation of CXXC5 De-Represses MYCL1 to Promote Hepatic Stellate Cell Activation.
Wu X; Dong W; Kong M; Ren H; Wang J; Shang L; Zhu Z; Zhu W; Shi X
Front Cell Dev Biol; 2021; 9():680344. PubMed ID: 34621736
[TBL] [Abstract][Full Text] [Related]
11. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
Stimson KM; Vertino PM
J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
[TBL] [Abstract][Full Text] [Related]
12. Zinc-finger protein CXXC5 promotes breast carcinogenesis by regulating the TSC1/mTOR signaling pathway.
Wang W; Zhang Z; Zhao M; Wang Y; Ge Y; Shan L
J Biol Chem; 2023 Jan; 299(1):102812. PubMed ID: 36539038
[TBL] [Abstract][Full Text] [Related]
13. CXXC5 drove inflammation and ovarian cancer proliferation via transcriptional activation of ZNF143 and EGR1.
Geng T; Sun Q; He J; Chen Y; Cheng W; Shen J; Liu B; Zhang M; Wang S; Asan K; Song M; Gao Q; Song Y; Liu R; Liu X; Ding Y; Jing A; Ye X; Ren H; Zeng K; Zhou Y; Zhang B; Ma S; Liu W; Liu S; Ji J
Cell Signal; 2024 Jul; 119():111180. PubMed ID: 38642782
[TBL] [Abstract][Full Text] [Related]
14. An unmethylated 3' promoter-proximal region is required for efficient transcription initiation.
Appanah R; Dickerson DR; Goyal P; Groudine M; Lorincz MC
PLoS Genet; 2007 Feb; 3(2):e27. PubMed ID: 17305432
[TBL] [Abstract][Full Text] [Related]
15. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
16. [A CxxC domain that binds to unmethylated CpG is required for KDM2A to control rDNA transcription].
Tsuneoka M; Tanaka Y; Okamoto K
Yakugaku Zasshi; 2015; 135(1):11-21. PubMed ID: 25743893
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter.
Han H; Cortez CC; Yang X; Nichols PW; Jones PA; Liang G
Hum Mol Genet; 2011 Nov; 20(22):4299-310. PubMed ID: 21835883
[TBL] [Abstract][Full Text] [Related]
18. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
19. Genomic organization and expression of a human gene for Myc-associated zinc finger protein (MAZ).
Song J; Murakami H; Tsutsui H; Tang X; Matsumura M; Itakura K; Kanazawa I; Sun K; Yokoyama KK
J Biol Chem; 1998 Aug; 273(32):20603-14. PubMed ID: 9685418
[TBL] [Abstract][Full Text] [Related]
20. Methylation patterns of the human beta-glucuronidase gene locus: boundaries of methylation and general implications for frequent point mutations at CpG dinucleotides.
Tomatsu S; Orii KO; Islam MR; Shah GN; Grubb JH; Sukegawa K; Suzuki Y; Orii T; Kondo N; Sly WS
Genomics; 2002 Mar; 79(3):363-75. PubMed ID: 11863366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
